PriceTargets.com logo

Agilent Technologies - A Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $144.36
  • Forecasted Upside: 12.28%
  • Number of Analysts: 14
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 8 Buy Ratings
  • 0 Strong Buy Ratings
$128.57 As of 11/20/2024 01:00 AM ET
▲ +2.88 (2.29%)

This chart shows the closing price for A by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Agilent Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for A and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for A

Analyst Price Target is $144.36
▲ +12.28% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Agilent Technologies in the last 3 months. The average price target is $144.36, with a high forecast of $165.00 and a low forecast of $90.00. The average price target represents a 12.28% upside from the last price of $128.57.

This chart shows the closing price for A for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 14 contributing investment analysts is to moderate buy stock in Agilent Technologies. This rating has held steady since September 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 9 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 11 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 8 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/15/2024BarclaysBoost TargetUnderweight ➝ Underweight$135.00 ➝ $145.00
10/1/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$135.00 ➝ $145.00
8/27/2024Wells Fargo & CompanyInitiated CoverageOverweight$157.00
8/26/2024Stifel NicolausReiterated RatingBuy$151.00
8/23/2024BarclaysBoost TargetUnderweight ➝ Underweight$125.00 ➝ $135.00
8/22/2024UBS GroupBoost TargetNeutral ➝ Neutral$141.00 ➝ $150.00
8/22/2024CitigroupBoost TargetBuy ➝ Buy$150.00 ➝ $165.00
8/22/2024TD CowenBoost TargetBuy ➝ Buy$153.00 ➝ $160.00
8/22/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$130.00 ➝ $135.00
8/22/2024Bank of AmericaBoost TargetNeutral ➝ Neutral$140.00 ➝ $147.00
7/29/2024TD CowenReiterated RatingBuy$153.00
7/10/2024CitigroupUpgradeNeutral ➝ Buy$135.00 ➝ $150.00
7/2/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$126.00 ➝ $130.00
6/27/2024Wolfe ResearchDowngradeOutperform ➝ Peer Perform
6/25/2024Bank of AmericaBoost TargetNeutral ➝ Neutral$134.00 ➝ $140.00
6/3/2024Jefferies Financial GroupReiterated RatingBuy ➝ Hold$152.00 ➝ $135.00
5/31/2024BarclaysLower TargetUnderweight ➝ Underweight$135.00 ➝ $125.00
5/30/2024CitigroupLower TargetNeutral ➝ Neutral$145.00 ➝ $135.00
5/30/2024JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$165.00 ➝ $155.00
5/30/2024TD CowenLower TargetBuy ➝ Buy$163.00 ➝ $153.00
5/30/2024UBS GroupLower TargetNeutral ➝ Neutral$155.00 ➝ $141.00
5/30/2024Bank of AmericaReiterated RatingNeutral ➝ Neutral$145.00 ➝ $134.00
5/30/2024Evercore ISILower TargetIn-Line ➝ In-Line$145.00 ➝ $126.00
5/30/2024Stifel NicolausLower TargetBuy ➝ Buy$163.00 ➝ $151.00
5/30/2024Robert W. BairdLower TargetOutperform ➝ Outperform$147.00 ➝ $136.00
4/10/2024BarclaysBoost TargetUnderweight ➝ Underweight$125.00 ➝ $135.00
4/5/2024Stifel NicolausUpgradeHold ➝ Buy$145.00 ➝ $163.00
4/4/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$132.00 ➝ $145.00
3/26/2024OppenheimerBoost TargetOutperform ➝ Outperform$67.00 ➝ $90.00
2/28/2024UBS GroupBoost TargetNeutral ➝ Neutral$130.00 ➝ $155.00
2/28/2024CitigroupBoost TargetNeutral ➝ Neutral$130.00 ➝ $145.00
2/28/2024Evercore ISILower TargetIn-Line ➝ In-Line$135.00 ➝ $132.00
2/28/2024BarclaysBoost TargetUnderweight ➝ Underweight$120.00 ➝ $125.00
1/25/2024BarclaysBoost TargetUnderweight ➝ Underweight$100.00 ➝ $120.00
12/20/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$140.00 ➝ $165.00
12/13/2023Wolfe ResearchInitiated CoverageOutperform$140.00
12/12/2023Bank of AmericaDowngradeBuy ➝ Neutral$130.00 ➝ $133.00
12/7/2023The Goldman Sachs GroupBoost TargetBuy ➝ Buy$128.00 ➝ $145.00
11/22/2023Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$160.00 ➝ $145.00
11/21/2023Robert W. BairdLower TargetOutperform ➝ Outperform$140.00 ➝ $130.00
11/17/2023UBS GroupDowngradeBuy ➝ Neutral$163.00 ➝ $125.00
9/29/2023BarclaysLower TargetUnderweight ➝ Underweight$110.00 ➝ $105.00
9/28/2023Sanford C. BernsteinInitiated CoverageMarket Perform$123.00
8/16/2023TD CowenBoost TargetOutperform ➝ Outperform$145.00 ➝ $147.00
8/16/2023Evercore ISILower TargetIn-Line ➝ In-Line$124.00 ➝ $120.00
8/16/2023Jefferies Financial GroupLower TargetBuy ➝ Buy$150.00 ➝ $146.00
8/16/2023JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$155.00 ➝ $150.00
8/16/2023Robert W. BairdLower TargetOutperform ➝ Outperform$144.00 ➝ $140.00
8/16/2023Credit Suisse GroupLower TargetOutperform ➝ Outperform$160.00 ➝ $150.00
8/16/2023BarclaysLower TargetUnderweight ➝ Underweight$115.00 ➝ $110.00
7/31/2023BarclaysDowngradeEqual Weight ➝ Underweight$116.00
6/27/2023BarclaysLower Target$135.00 ➝ $130.00
5/24/2023888Reiterated RatingMaintains
5/24/202358.comReiterated RatingMaintains
5/24/2023TD CowenLower TargetOutperform$168.00 ➝ $145.00
5/24/2023SVB SecuritiesLower TargetOutperform$170.00 ➝ $145.00
5/24/2023Evercore ISILower TargetOutperform$150.00 ➝ $126.00
5/24/2023Bank of AmericaLower TargetBuy$164.00 ➝ $144.00
5/24/2023Stifel NicolausLower TargetHold$153.00 ➝ $135.00
5/24/2023Robert W. BairdLower TargetOutperform$174.00 ➝ $144.00
5/24/2023Credit Suisse GroupLower TargetOutperform$170.00 ➝ $160.00
5/24/2023Wells Fargo & CompanyLower TargetOverweight$170.00 ➝ $160.00
5/24/2023CitigroupLower TargetNeutral$150.00 ➝ $130.00
5/24/2023BarclaysLower TargetEqual Weight$140.00 ➝ $135.00
5/11/2023BarclaysInitiated CoverageEqual Weight$140.00
3/1/2023Credit Suisse GroupBoost TargetOutperform$165.00 ➝ $170.00
3/1/2023Robert W. BairdBoost TargetOutperform$170.00 ➝ $174.00
1/10/2023Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$150.00 ➝ $170.00
1/6/2023Leerink PartnersBoost TargetOutperform$160.00 ➝ $170.00
12/20/2022UBS GroupBoost TargetBuy$152.00 ➝ $170.00
11/22/2022CowenBoost Target$160.00 ➝ $168.00
11/22/2022Jefferies Financial GroupBoost Target$158.00 ➝ $168.00
11/22/2022Evercore ISIBoost Target$140.00 ➝ $155.00
11/22/2022CowenBoost Target$160.00 ➝ $168.00
11/22/2022Wells Fargo & CompanyBoost Target$135.00 ➝ $150.00
11/22/2022Robert W. BairdBoost Target$160.00 ➝ $170.00
11/22/2022CitigroupBoost TargetNeutral$145.00 ➝ $150.00
11/22/2022Leerink PartnersBoost TargetOutperform$145.00 ➝ $160.00
11/22/2022KeyCorpBoost TargetOverweight$155.00 ➝ $165.00
8/24/2022Credit Suisse GroupInitiated CoverageOutperform$165.00
8/22/2022Evercore ISIBoost Target$145.00
8/22/2022CowenBoost Target$160.00
8/17/2022Bank of AmericaBoost TargetBuy$148.00 ➝ $155.00
8/17/2022Wells Fargo & CompanyBoost TargetEqual Weight$130.00 ➝ $135.00
8/17/2022CitigroupBoost TargetNeutral$140.00 ➝ $145.00
8/17/2022Robert W. BairdBoost TargetOutperform$155.00 ➝ $160.00
7/20/2022UBS GroupInitiated CoverageBuy$139.00
7/14/2022The Goldman Sachs GroupLower TargetBuy$170.00 ➝ $140.00
7/8/2022CitigroupDowngradeBuy ➝ Neutral$175.00 ➝ $140.00
6/2/2022KeyCorpLower TargetOverweight$195.00 ➝ $155.00
5/26/2022The Goldman Sachs GroupReiterated RatingBuy$170.00
5/25/2022Robert W. BairdBoost TargetOutperform$155.00 ➝ $161.00
4/25/2022Wells Fargo & CompanyLower TargetOverweight ➝ Equal Weight$160.00 ➝ $130.00
4/19/2022Truist FinancialDowngradeBuy ➝ Hold
2/23/2022Evercore ISILower TargetOutperform$170.00 ➝ $155.00
2/23/2022Bank of AmericaLower TargetBuy$179.00 ➝ $160.00
2/23/2022CowenLower TargetOutperform$187.00 ➝ $178.00
2/23/2022Stifel NicolausLower TargetHold$169.00 ➝ $145.00
2/23/2022Wells Fargo & CompanyLower TargetOverweight$180.00 ➝ $160.00
2/23/2022Robert W. BairdLower Target$170.00 ➝ $161.00
2/23/2022CitigroupLower TargetBuy$190.00 ➝ $175.00
2/23/2022Leerink PartnersLower TargetOutperform$175.00 ➝ $145.00
11/23/2021CowenBoost TargetHold ➝ Outperform$180.00 ➝ $187.00
11/23/2021Stifel NicolausBoost TargetHold$162.00 ➝ $169.00
11/23/2021Bank of AmericaBoost TargetBuy$177.00 ➝ $179.00
11/23/2021Leerink PartnersBoost TargetOutperform$170.00 ➝ $175.00
10/14/2021CowenLower TargetOutperform$200.00 ➝ $180.00
9/17/2021CowenBoost TargetOutperform$165.00 ➝ $200.00
8/18/2021CowenBoost TargetOutperform$150.00 ➝ $165.00
8/18/2021Jefferies Financial GroupBoost TargetBuy$155.00 ➝ $185.00
8/18/2021Wells Fargo & CompanyBoost TargetOverweight$150.00 ➝ $180.00
8/18/2021Leerink PartnersBoost TargetOutperform$160.00 ➝ $170.00
8/18/2021KeyCorpBoost TargetPositive ➝ Overweight$160.00 ➝ $195.00
8/18/2021Stifel NicolausBoost TargetHold$136.00 ➝ $162.00
8/18/2021Robert W. BairdBoost TargetOutperform$144.00 ➝ $170.00
8/18/2021CitigroupBoost TargetBuy$160.00 ➝ $190.00
7/12/2021KeyCorpBoost TargetOverweight$157.00 ➝ $160.00
6/22/2021Societe GeneraleUpgradeHold ➝ Buy
5/26/2021KeyCorpBoost TargetOverweight$148.00 ➝ $157.00
5/26/2021Leerink PartnersBoost TargetOutperform$140.00 ➝ $145.00
5/26/2021Wells Fargo & CompanyBoost TargetOverweight$140.00 ➝ $150.00
5/26/2021Robert W. BairdBoost TargetOutperform$137.00 ➝ $144.00
5/26/2021CitigroupBoost TargetBuy$150.00 ➝ $160.00
3/19/2021Redburn PartnersUpgradeNeutral ➝ Buy
3/18/2021CitigroupUpgradeNeutral ➝ Buy$150.00
2/17/2021KeyCorpBoost Target$130.00 ➝ $148.00
2/17/2021CitigroupBoost Target$120.00 ➝ $135.00
2/17/2021Robert W. BairdBoost TargetOutperform$133.00 ➝ $137.00
2/17/2021Wells Fargo & CompanyBoost TargetOverweight$120.00 ➝ $140.00
2/17/2021CowenBoost TargetOutperform$125.00 ➝ $135.00
2/17/2021Leerink PartnersBoost TargetOutperform$130.00 ➝ $140.00
2/17/2021Bank of AmericaUpgradeNeutral ➝ Buy$147.00
1/12/2021MizuhoInitiated CoverageBuy$51.00
12/23/2020MKM PartnersInitiated CoverageBuy$57.00
12/15/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$49.00
12/10/2020Leerink PartnersBoost TargetOutperform$120.00 ➝ $130.00
12/3/2020Sanford C. BernsteinUpgradeMarket Perform ➝ Outperform
12/2/2020The Goldman Sachs GroupInitiated CoverageBuy$130.00
11/25/2020UBS GroupUpgradeNeutral ➝ Buy$103.00 ➝ $132.00
11/24/2020JPMorgan Chase & Co.Boost TargetOverweight$110.00 ➝ $125.00
11/24/2020Wells Fargo & CompanyBoost TargetOverweight$105.00 ➝ $120.00
11/24/2020Robert W. BairdBoost TargetOutperform$104.00 ➝ $118.00
11/24/2020Leerink PartnersBoost TargetOutperform$100.00 ➝ $120.00
11/9/2020KeyCorpInitiated CoverageOverweight$130.00
11/9/2020HSBCUpgradeHold ➝ Buy$30.70
11/3/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight
9/30/2020Atlantic SecuritiesInitiated CoverageNeutral$105.00
8/25/2020Stifel NicolausLower TargetHold$39.00 ➝ $37.00
8/19/2020Bank of AmericaBoost TargetNeutral$99.00 ➝ $103.00
8/19/2020Stifel NicolausBoost TargetHold$85.00 ➝ $100.00
8/19/2020Jefferies Financial GroupBoost TargetBuy$95.00 ➝ $110.00
8/19/2020Leerink PartnersBoost TargetOutperform$95.00 ➝ $100.00
8/19/2020Robert W. BairdBoost TargetOutperform$87.00 ➝ $104.00
8/19/2020Needham & Company LLCReiterated RatingHold
8/19/2020CitigroupBoost TargetNeutral$85.00 ➝ $100.00
8/19/2020Wells Fargo & CompanyReiterated RatingOverweight$100.00 ➝ $105.00
7/27/2020Credit Suisse GroupBoost TargetNeutral$53.00 ➝ $54.00
7/20/2020Bank of AmericaBoost TargetNeutral$88.00 ➝ $99.00
7/13/2020The Goldman Sachs GroupInitiated CoverageNeutral
7/1/2020The Goldman Sachs GroupReiterated RatingBuy ➝ Neutral
5/22/2020CfraLower TargetHold$89.00 ➝ $85.00
5/22/2020Bank of AmericaBoost TargetNeutral$74.00 ➝ $88.00
5/22/2020UBS GroupBoost TargetNeutral$84.00 ➝ $87.00
5/22/2020CowenBoost TargetOutperform$80.00 ➝ $95.00
5/22/2020Wells Fargo & CompanyBoost TargetOverweight$82.00 ➝ $95.00
5/22/2020Leerink PartnersBoost TargetOutperform$90.00 ➝ $95.00
4/28/2020Royal Bank of CanadaInitiated CoverageSector Perform
4/28/2020UBS GroupLower TargetNeutral$90.00 ➝ $84.00
4/16/2020SunTrust BanksLower TargetHold$90.00 ➝ $75.00
4/2/2020Stifel NicolausLower TargetHold$85.00 ➝ $73.00
3/30/2020Wells Fargo & CompanyLower TargetOverweight$100.00 ➝ $82.00
3/26/2020BarclaysLower TargetEqual Weight$85.00 ➝ $76.00
3/20/2020CitigroupLower TargetNeutral$85.00 ➝ $75.00
2/24/2020Needham & Company LLCDowngradeBuy ➝ Hold$85.00
2/21/2020CfraLower TargetHold$60.00 ➝ $57.00
2/19/2020Piper SandlerBoost TargetOverweight$86.00 ➝ $96.00
2/19/2020UBS GroupBoost TargetBuy ➝ Neutral$87.00 ➝ $90.00
2/12/2020HSBCUpgradeHold ➝ Buy
1/28/2020UBS GroupReiterated RatingBuy
1/7/2020Wells Fargo & CompanyInitiated CoverageOverweight$100.00 ➝ $100.00
1/6/2020CitigroupInitiated CoverageNeutral$85.00
1/3/2020Needham & Company LLCInitiated CoverageBuy$77.00
11/26/2019UBS GroupBoost TargetNeutral$82.00 ➝ $87.00
11/26/2019JPMorgan Chase & Co.Boost TargetOverweight$85.00 ➝ $90.00
11/26/2019Needham & Company LLCReiterated RatingBuy$92.00 ➝ $85.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

1.29 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 29 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024
  • 24 very positive mentions
  • 19 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 33 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 25 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 32 very positive mentions
  • 36 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 29 very positive mentions
  • 26 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 23 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 39 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024

Current Sentiment

  • 39 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Agilent Technologies logo
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Read More

Today's Range

Now: $128.57
Low: $124.89
High: $128.71

50 Day Range

MA: $138.06
Low: $125.70
High: $148.48

52 Week Range

Now: $128.57
Low: $121.23
High: $155.35

Volume

1,695,972 shs

Average Volume

1,706,543 shs

Market Capitalization

$36.94 billion

P/E Ratio

26.67

Dividend Yield

0.74%

Beta

1.07

Frequently Asked Questions

What sell-side analysts currently cover shares of Agilent Technologies?

The following equities research analysts have issued stock ratings on Agilent Technologies in the last year: Bank of America Co., Barclays PLC, Citigroup Inc., Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Oppenheimer Holdings Inc., Robert W. Baird, Stifel Nicolaus, StockNews.com, TD Cowen, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for A.

What is the current price target for Agilent Technologies?

0 Wall Street analysts have set twelve-month price targets for Agilent Technologies in the last year. Their average twelve-month price target is $144.36, suggesting a possible upside of 12.3%. Citigroup Inc. has the highest price target set, predicting A will reach $165.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $90.00 for Agilent Technologies in the next year.
View the latest price targets for A.

What is the current consensus analyst rating for Agilent Technologies?

Agilent Technologies currently has 1 sell rating, 5 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for A.

What other companies compete with Agilent Technologies?

Other companies that are similar to Agilent Technologies include Keysight Technologies, Fortive, Mettler-Toledo International, Illumina and Waters. Learn More about companies similar to Agilent Technologies.

How do I contact Agilent Technologies' investor relations team?

Agilent Technologies' physical mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company's listed phone number is (800) 227-9770 and its investor relations email address is [email protected]. The official website for Agilent Technologies is www.agilent.com. Learn More about contacing Agilent Technologies investor relations.